[PR Newswire] - ROCKVILLE, Md., April 19, 2013 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE MKT: SYN), a developer of biologics focused on the prevention and treatment of serious infectious diseases, reiterated that ...
You are receiving this email because you subscribed to this feed at blogtrottr.com.
No comments:
Post a Comment